New York State Common Retirement Fund »

Mirum Pharmaceuticals Inc Note 4.000 5/0 shares owned by New York State Common Retirement Fund

Quarter-by-quarter ownership of Mirum Pharmaceuticals Inc Note 4.000 5/0 shares owned by New York State Common Retirement Fund from 13F filings

Historical chart of New York State Common Retirement Fund investment in Mirum Pharmaceuticals Inc Note 4.000 5/0

Tip: Access up to 7 years of quarterly data

All positions including Mirum Pharmaceuticals Inc Note 4.000 5/0 held by New York State Common Retirement Fund consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mirum Pharmaceuticals Inc Note 4.000 5/0 by New York State Common Retirement Fund

Quarter filed Position value Share count Share price at filing
2024-06-30 $2.6M 2.0M 1.34

More positions owned by New York State Common Retirement Fund

Microsoft Corporation Common Stock (MSFT)
Apple Common Stock (AAPL)
Nvidia Corporation Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Alphabet Inc - Class A Common Stock (GOOGL)
Meta Platforms Common Stock (META)
Alphabet Inc - Class C Common Stock (GOOG)
Eli Lilly & Company Common Stock (LLY)
Broadcom Common Stock (AVGO)
Berkshire Hathaway Inc-cl Common Stock (BRK.B)
Jp Morgan Chase & Company Common Stock (JPM)
Tesla Common Stock (TSLA)
Unitedhealth Group Common Stock (UNH)
Exxon Mobil Corporation Common Stock (XOM)
Visa Inc - Class A Common Stock (V)

View all positions for New York State Common Retirement Fund

Top funds holding Mirum Pharmaceuticals Inc Note 4.000 5/0

Deerfield Management Company
Wolverine Asset Management
Readystate Asset Management
MacKay Shields
Franklin Resources
Advent Capital Management
Point72 Asset Management
SSI Investment Management
BlackRock
Jpmorgan Chase & Co
Tang Capital Management
Kornitzer Capital Management
Bnp Paribas Arbitrage, Snc
New York State Common Retirement Fund
Citigroup

View all funds holding Mirum Pharmaceuticals Inc Note 4.000 5/0